Literature DB >> 30886417

Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.

Liang Ye1, Daniel Schnepf1,2, Jan Becker1, Karolina Ebert3, Yakup Tanriver3,4,5, Valentina Bernasconi6, Hans Henrik Gad7, Rune Hartmann7, Nils Lycke6, Peter Staeheli8,9.   

Abstract

Interferon-λ (IFN-λ) acts on mucosal epithelial cells and thereby confers direct antiviral protection. In contrast, the role of IFN-λ in adaptive immunity is far less clear. Here, we report that mice deficient in IFN-λ signaling exhibited impaired CD8+ T cell and antibody responses after infection with a live-attenuated influenza virus. Virus-induced release of IFN-λ triggered the synthesis of thymic stromal lymphopoietin (TSLP) by M cells in the upper airways that, in turn, stimulated migratory dendritic cells and boosted antigen-dependent germinal center reactions in draining lymph nodes. The IFN-λ-TSLP axis also boosted production of the immunoglobulins IgG1 and IgA after intranasal immunization with influenza virus subunit vaccines and improved survival of mice after challenge with virulent influenza viruses. IFN-λ did not influence the efficacy of vaccines applied by subcutaneous or intraperitoneal routes, indicating that IFN-λ plays a vital role in potentiating adaptive immune responses that initiate at mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30886417     DOI: 10.1038/s41590-019-0345-x

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  1 in total

1.  Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.

Authors:  Silvie Van den Hoecke; Katrin Ehrhardt; Annasaheb Kolpe; Karim El Bakkouri; Lei Deng; Hendrik Grootaert; Steve Schoonooghe; Anouk Smet; Mostafa Bentahir; Kenny Roose; Michael Schotsaert; Bert Schepens; Nico Callewaert; Falk Nimmerjahn; Peter Staeheli; Hartmut Hengel; Xavier Saelens
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

  1 in total
  30 in total

1.  Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.

Authors:  Liang Ye; Annette Ohnemus; Li Ching Ong; Hans Henrik Gad; Rune Hartmann; Nils Lycke; Peter Staeheli
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.

Authors:  Michelle Møhlenberg; Ida Monrad; Line K Vibholm; Stine S F Nielsen; Giacomo Schmidt Frattari; Mariane Høgsbjerg Schleimann; Rikke Olesen; Mads Kjolby; Jesper Damsgaard Gunst; Ole Schmeltz Søgaard; Thomas R O'Brien; Martin Tolstrup; Rune Hartmann
Journal:  J Interferon Cytokine Res       Date:  2021-11       Impact factor: 2.607

3.  Targeting IFN-λ Signaling Promotes Recovery from Central Nervous System Autoimmunity.

Authors:  Sindhu Manivasagam; Jessica L Williams; Lauren L Vollmer; Bryan Bollman; Juliet M Bartleson; Shenjian Ai; Gregory F Wu; Robyn S Klein
Journal:  J Immunol       Date:  2022-02-18       Impact factor: 5.426

4.  Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.

Authors:  Amir Ghorbani; Michael C Abundo; Hana Ji; Kara J M Taylor; John M Ngunjiri; Chang-Won Lee
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 5.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

Review 6.  Quantifying between-Host Transmission in Influenza Virus Infections.

Authors:  Katherine E E Johnson; Elodie Ghedin
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

7.  Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.

Authors:  Megan L Stanifer; Carmon Kee; Mirko Cortese; Camila Metz Zumaran; Sergio Triana; Markus Mukenhirn; Hans-Georg Kraeusslich; Theodore Alexandrov; Ralf Bartenschlager; Steeve Boulant
Journal:  Cell Rep       Date:  2020-06-19       Impact factor: 9.423

8.  Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.

Authors:  Deanna M Santer; Gillian E S Minty; Dominic P Golec; Julia Lu; Julia May; Afshin Namdar; Juhi Shah; Shokrollah Elahi; David Proud; Michael Joyce; D Lorne Tyrrell; Michael Houghton
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

9.  What makes the hepatitis C virus evolve?

Authors:  Thomas R O'Brien; Rune Hartmann; Ludmila Prokunina-Olsson
Journal:  Elife       Date:  2019-09-03       Impact factor: 8.140

10.  Outdoor Endurance Training with Air Pollutant Exposure Versus Sedentary Lifestyle: A Comparison of Airway Immune Responses.

Authors:  Juliana de Melo Batista Dos Santos; Roberta Foster; Anne-Charlotte Jonckheere; Marcelo Rossi; Luiz Antonio Luna Junior; Catherine Machado Katekaru; Matheus Cavalcante de Sá; Lucas Guimarães Pagani; Francine Maria de Almeida; Jônatas do Bussador Amaral; Rodolfo de Paula Vieira; Andre Luis Lacerda Bachi; Dominique Magdalena A Bullens; Mauro Vaisberg
Journal:  Int J Environ Res Public Health       Date:  2019-11-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.